User:Mr. Ibrahem/Enzalutamide

Enzalutamide, sold under the brand name Xtandi, is a medication used to treat prostate cancer. Specifically it is us to treat castration-resistant prostate cancer (mCRPC), and metastatic castration-sensitive prostate cancer (mCSPC). It is taken by mouth.

Common side effects include tiredness, back pain, diarrhea, joint pain, high blood pressure, and hot flashes. Other side effects may include seizures, posterior reversible encephalopathy syndrome, allergic reactions, and falls. Use during pregnancy, including by the male, may harm the baby. There are a number of medication interactions. It is a nonsteroidal antiandrogen (NSAA) which works by blocking androgens like testosterone, from binding to the androgen receptor.

Enzalutamide was patented in 2006 and approved for medical use in the United States in 2012. It is on the World Health Organization's List of Essential Medicines as an alternative abiraterone. In the United Kingdom 4 weeks of treatment costs the NHS about £2,700 as of 2021. This amount in the United States costs about 12,000 USD.